Active substance
Results for the substance peginterferon alfa 2a
5 results
About this active substance
Peginterferon alfa-2a is an immunomodulatory agent used in the treatment of chronic hepatitis B and C. It works by stimulating the body's immune response to fight viral infections.
The medication is administered subcutaneously, as directed by a doctor, usually once a week. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the response to therapy.
Patients should be aware of potential side effects, such as fatigue, fever, or flu-like symptoms. It is important to inform the doctor of any unusual symptoms.
Common side effects include fatigue, fever, and flu-like symptoms. In rare cases, severe reactions such as depression or hematologic disorders may occur. Patients should be informed of these risks before use.
The medication is administered subcutaneously, as directed by a doctor, usually once a week. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the response to therapy.
Patients should be aware of potential side effects, such as fatigue, fever, or flu-like symptoms. It is important to inform the doctor of any unusual symptoms.
Common side effects include fatigue, fever, and flu-like symptoms. In rare cases, severe reactions such as depression or hematologic disorders may occur. Patients should be informed of these risks before use.
-
-
PEGASYS 135mcg/0.5ml solution for injection in pre-filled syringe EGIS ORIGINAL MEDICINE
-
PEGASYS 135 AG 135mcg/0.5ml solution for injection EGIS ORIGINAL MEDICINE
-
PEGASYS 135mcg/ml solution for injection EGIS ORIGINAL MEDICINE
-
PEGASYS 180mcg/ml solution for injection EGIS ORIGINAL MEDICINE